Understanding how bacteria use toxins to inhibit each other's growth
Function of novel antibacterial toxins
This study is looking at how some bacteria can produce toxins to stop other bacteria from growing, which could help us find new ways to fight bacterial infections.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Santa Barbara NIH-funded |
| Lab location | 1 site (Santa Barbara, United States) |
| Project ID | NIH-11076797 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which certain bacteria produce toxins that can inhibit the growth of competing bacteria. It focuses on a specific system known as contact-dependent growth inhibition (CDI), which involves proteins that allow one bacterium to deliver toxic substances to another. By employing genetic, biochemical, and biophysical methods, the research aims to uncover the interactions between these proteins and how they contribute to bacterial competition. This knowledge could lead to new strategies for combating bacterial infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from infections caused by Gram-negative bacteria, particularly those resistant to current treatments.
Not a fit: Patients with infections caused by Gram-positive bacteria or those not affected by bacterial toxins may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of novel antibacterial therapies that target specific bacterial interactions.
How similar studies have performed: Previous research has shown promise in understanding bacterial competition and toxin mechanisms, indicating that this approach could yield valuable insights.
Where this research is happening
Santa Barbara, United States
- University of California Santa Barbara — Santa Barbara, United States (Active)
Researchers
- Principal investigator: Hayes, Christopher S. — University of California Santa Barbara
- Study coordinator: Hayes, Christopher S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.